130 related articles for article (PubMed ID: 8101873)
21. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
22. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis.
Wiley CA; Achim CL; Schrier RD; Heyes MP; McCutchan JA; Grant I
AIDS; 1992 Nov; 6(11):1299-307. PubMed ID: 1472335
[TBL] [Abstract][Full Text] [Related]
23. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
24. Early markers of HIV infection and subclinical disease progression.
Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine.
Hagberg L; Norkrans G; Gisslen M; Wachter H; Fuchs D; Svennerholm B
Scand J Infect Dis; 1996; 28(4):329-33. PubMed ID: 8893393
[TBL] [Abstract][Full Text] [Related]
26. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.
Graham NM; Park LP; Piantadosi S; Phair JP; Mellors J; Fahey JL; Saah AJ
Clin Infect Dis; 1995 Feb; 20(2):352-62. PubMed ID: 7742442
[TBL] [Abstract][Full Text] [Related]
28. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.
Heyes MP; Ellis RJ; Ryan L; Childers ME; Grant I; Wolfson T; Archibald S; Jernigan TL;
Brain; 2001 May; 124(Pt 5):1033-42. PubMed ID: 11335705
[TBL] [Abstract][Full Text] [Related]
29. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
30. Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1.
Lucey DR; McGuire SA; Clerici M; Hall K; Benton J; Butzin CA; Ward WW; Shearer G; Boswell RN; Hendrix CW
J Infect Dis; 1991 May; 163(5):971-5. PubMed ID: 1673466
[TBL] [Abstract][Full Text] [Related]
31. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
[TBL] [Abstract][Full Text] [Related]
32. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
34. Neopterin and beta 2-microglobulin and the assessment of intra-blood-brain-barrier synthesis of HIV-specific and total IgG.
Peter JB; McKeown KL; Barka NE; Tourtellotte WW; Singer EJ; Syndulko K
J Clin Lab Anal; 1991; 5(5):317-20. PubMed ID: 1941351
[TBL] [Abstract][Full Text] [Related]
35. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
[TBL] [Abstract][Full Text] [Related]
36. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.
Frissen PH; Weverling GJ; Endert E; Jansen J; Sauerwein HP; Lange JM
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):482-8. PubMed ID: 8757425
[TBL] [Abstract][Full Text] [Related]
37. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
[TBL] [Abstract][Full Text] [Related]
39. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
[TBL] [Abstract][Full Text] [Related]
40. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]